FDA Adverse Event Injury Summary report: N

PELVISOFT ACELLULAR COLLAGEN BIOMESH

MDR report key: 3223797 · Received July 10, 2013

Report

Report Number
1018233-2013-02758
Event Type
Injury
Date Received
July 10, 2013
Report Date
June 10, 2013
Manufacturer
TISSUE SCIENCE LABS
Product Code
FTM
PMA / PMN Number
K031332
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE WAS NOT RETURNED. THE FINISHED PRODUCT MET ALL SPECIFICATIONS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE PRECAUTIONS:"PELVISOFT BIOMESH IS FOR SINGLE-PATIENT USE ONLY AND IS TO BE IMPLANTED SURGICALLY. IF EITHER THE OUTER POLYESTER/POLYETHYLENE POUCH OR THE INNER FOIL POUCH HAS BEEN PERFORATED OR TORN IN SHIPMENT OR STORAGE, THEN THE ENCLOSED PELVISOFT BIOMESH SHOULD NOT BE USED. PELVISOFT BIOMESH SHOULD BE HYDRATED OR MOIST WHEN THE TISSUE SHOULD NOT BE IMPLANTED.(B)(4).

Description of Event or Problem · 1

(B)(4). THE PATIENT'S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. ADD'L INFO HAS BEEN REQUESTED, BUT NOT RECEIVED. ASSOCIATED MDRS: 1018233-2013-02756 AND 1018233-2013-02757.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
316020 PELVISOFT ACELLULAR COLLAGEN BIOMESH FTM TISSUE SCIENCE LABS NA 08B07-2

Patients

Seq Age Sex Outcome Treatment
1 72 YR Required Intervention PELVISOFT ACELLUAR COLLAGEN BIOMESH: 481047| LOT NUMBER: 08B02-1| LOT NUMBER: CVSJ0016| PELVILACE TO BIOURETHRAL SUPPORT SYSTEM 482151